15
Nov
Predicting cytomegalovirus viremia….with CMV-specific T-cells
in Abstracts
Predicting cytomegalovirus viremia after liver or intestine transplantation (LTx, ITx) with CMV-specific T-cell subsets
PERSONALIZED MEDICINE FOR BETTER HEALTH
10
Sep
FDA approves PleximmuneTM for personalized prediction of transplant rejection in children
PITTSBURGH, Sept. 11, 2014 /PRNewswire-iReach/ -- Today the FDA announced approval of PleximmuneTM, a blood test from the Pittsburgh-based biotech company Plexision. This test predicts acute cellular rejection of transplanted livers and intestines in children. PleximmuneTM is a first-in-class test to determine a personalized rejection-risk index using cell-based technology.
27
Nov
Prognostic cell-based assay predicts acute cellular rejection in pre- and post-transplant testing of children with liver and intestine transplantation (LTx, ITx).
Below is an extract of the original abstract from the Liver Meeting help in Washington DC.© The American Association for the Study of Liver Diseases. Original abstracts could be accessed via their site here
Pages
Categories
Popular Posts
- FDA approves PleximmuneTM for personalized prediction of transplant rejection in children
- American Transplant Congress, Seattle | 18–22 May 2013
- Prognostic cell-based assay predicts acute cellular rejection in pre- and post-transplant testing of children with liver and intestine transplantation (LTx, ITx).
- Predicting cytomegalovirus viremia….with CMV-specific T-cells
- Predicting Cellular Rejection With a Cell-Based Assay: Preclinical Evaluation in Children
- Pleximmune test to predict liver transplant rejection presented at the Liver meeting in Washington DC - November 3, 2013.
- Plexision's PK/PD solutions presented at CHI's Immunogenicity Summit in Washington, DC - November 11, 2013.
- ESOT Congress, Vienna | Sept 8-11
- Technology - How It Works
- Combined Biomarker and Drug Development
Archives
- February 2013 (2)
- August 2013 (1)
- October 2013 (1)
- November 2013 (3)
- September 2014 (1)
- March 2016 (1)
- November 2016 (1)